Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

F13A1 Antikörper (N-Term)

F13A1 Reaktivität: Human WB, IF, IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN2856753
  • Target Alle F13A1 Antikörper anzeigen
    F13A1 (Coagulation Factor XIII, A1 Polypeptide (F13A1))
    Bindungsspezifität
    • 24
    • 7
    • 5
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reaktivität
    • 81
    • 8
    • 7
    • 3
    • 3
    Human
    Wirt
    • 48
    • 33
    • 3
    • 1
    Kaninchen
    Klonalität
    • 50
    • 35
    Polyklonal
    Konjugat
    • 54
    • 6
    • 5
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser F13A1 Antikörper ist unkonjugiert
    Applikation
    • 47
    • 46
    • 31
    • 31
    • 24
    • 19
    • 15
    • 7
    • 6
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC)
    Kreuzreaktivität
    Human, Maus
    Produktmerkmale
    Rabbit polyclonal antibody to Factor XIIIa (coagulation factor XIII, A1 polypeptide)
    Factor XIIIa antibody [N1N3]
    Aufreinigung
    Purified by antigen-affinity chromatography.
    Immunogen
    Recombinant protein encompassing a sequence within the N-terminus region of human Factor XIIIa. The exact sequence is proprietary.
    Isotyp
    IgG
    Top Product
    Discover our top product F13A1 Primärantikörper
  • Applikationshinweise
    WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1.97 mg/mL
    Buffer
    1XPBS ( pH 7), 20 % Glycerol, 0.025 % ProClin 300
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
  • Target
    F13A1 (Coagulation Factor XIII, A1 Polypeptide (F13A1))
    Andere Bezeichnung
    coagulation factor XIII A chain (F13A1 Produkte)
    Synonyme
    F13a antikoerper, f13a1 antikoerper, wu:fo83d04 antikoerper, zgc:153334 antikoerper, F13A1 antikoerper, F13A antikoerper, 1200014I03Rik antikoerper, AI462306 antikoerper, coagulation factor XIII A1 chain antikoerper, coagulation factor XIII, A1 polypeptide b antikoerper, coagulation factor XIII A chain antikoerper, coagulation factor XIII, A1 subunit antikoerper, F13a1 antikoerper, f13a1b antikoerper, F13A1 antikoerper
    Hintergrund
    This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits, and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion.

    Cellular Localization: Cytoplasm , Secreted
    Molekulargewicht
    83 kDa
    Gen-ID
    2162
    UniProt
    P00488
Sie sind hier:
Kundenservice